# Gemcitabine Versus Water Irrigation in Upper Tract Urothelial Carcinoma

> **NCT04865939** · PHASE3 · RECRUITING · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 132 (estimated)

## Conditions studied

- Urothelial Cancer of Renal Pelvis
- Urothelial Carcinoma Ureter

## Interventions

- **PROCEDURE:** sterile water irrigation
- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT04865939
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-29
- **Primary completion:** 2029-11-01
- **Final completion:** 2031-11-01
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2025-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04865939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04865939, "Gemcitabine Versus Water Irrigation in Upper Tract Urothelial Carcinoma". Retrieved via AI Analytics 2026-09-23 from https://api.ai-analytics.org/clinical/NCT04865939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*